Paper·2026·Commentary
Paper·2025·Research article
De Novo Variants Predominate in Autism Spectrum Disorder
Boles RG, Bar O, Boles PT, Hill ZR, Frye RE
Genes, 2025
A plain-language summary is not written yet
The foundation is writing summaries of its papers, starting with the most important ones. Until then, the citation and the link to the journal are below.
Citation
Boles, R.G.; Bar, O.; Boles, P.T.; Hill, Z.R.; Frye, R.E. De Novo Variants Predominate in Autism Spectrum Disorder. Genes 2025, 16, 1099.
More on biomarkers
Paper·2025·Clinical trial
Mitochondrial Supplement Improves Function and Mitochondrial Activity in Autism: A Double-Blind Placebo-Controlled Cross-Over Trial
Paper·2024·Research article
Reanalysis of Trio Whole-Genome Sequencing Data Doubles the Yield in Autism Spectrum Disorder: De Novo Variants Present in Half
Paper·2024·Research article
Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder
Asks which blood marker predicts who responds to leucovorin, and points to the binding autoantibody.